Relugolix for pain caused by endometriosis
Part of Women’s health & pregnancy clinical trials.
This trial is testing a medicine called Relugolix to see how well it relieves pain from endometriosis, a condition where tissue similar to the womb lining grows outside the womb. It might help people with moderate to severe pain that hasn't improved with other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 18 to 50.
- You must have endometriosis confirmed by a previous surgery or imaging test like an ultrasound or MRI.
- You must be currently taking Relugolix (the study drug) and have been for at least one month.
- You must have pelvic pain that is at least 40 out of 100 on a pain scale.
- You must have regular menstrual periods (you cannot be in menopause or have had your ovaries removed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a drug called relugolix CT can reduce pelvic pain from endometriosis. You'll have brain scans and pain tests to measure how your body processes pain. It might help if other treatments haven't worked well.
This trial tests whether taking a medication (Rel-CT) after surgery helps improve outcomes for people with endometriosis. It may reduce the chance of symptoms returning after the tissue is removed.
This study tests a non-hormonal medication (rinegepant, used for migraines) to see if it can reduce endometriosis pain. It involves taking the medication daily and keeping a pain diary for 12 weeks.
This trial tests a new drug called GenSci048 to see if it can reduce moderate to severe pain caused by endometriosis. It might be an option if you have regular periods and are willing to switch to only the pain relievers allowed in the study.
This trial tests an experimental drug called HMI-115 to see if it reduces pain from endometriosis. If you have moderate to severe period pain and non-period pain, and you have a surgical diagnosis, you may be able to join.
This study tests how well a long-term treatment using a relugolix combination tablet helps protect bone density in women who have uterine fibroids or endometriosis. It may help people who are at risk of bone thinning while receiving hormone-related symptom treatment.
Hear when a new Endometriosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.